Metastasis-associated in colon cancer 1 (MACC1) mRNA (MACC1 mRNA)

Metastasis-associated in colon cancer 1 (MACC1) is a critical regulator of the hepatocyte growth factor (HGF)/MET signaling pathway, acting as a transcription factor that binds to the MET promoter to induce its expression (Stein et al., 2009, Nature Medicine). MACC1 mRNA levels serve as a potent prognostic biomarker, as high expression is strongly correlated with tumor progression, metastasis, and reduced survival in colorectal cancer and various other solid tumors (Dahlmann et al., 2014, British Journal of Cancer). By promoting epithelial-mesenchymal transition (EMT), cell migration, and invasion, MACC1 facilitates the dissemination of cancer cells from the primary tumor to distant organs. Therapeutic strategies targeting MACC1 mRNA include the use of small molecules like statins (e.g., Lovastatin, Pitavastatin), which have been shown to inhibit MACC1 promoter activity and reduce mRNA levels, thereby suppressing metastasis in preclinical models (Dahlmann et al., 2014). Additionally, experimental approaches such as RNA interference (RNAi) and antisense oligonucleotides (ASOs) are being explored to directly degrade MACC1 mRNA or block its translation to achieve therapeutic effects (Schmid et al., 2012, Expert Opinion on Therapeutic Targets).

Other names

Metastasis-associated in colon cancer protein 1 mRNASH3BP4L mRNAMACC-1 mRNA

Inhibition of MACC1 transcription via promoter suppression and mRNA degradation through RNA interference or antisense oligonucleotides